CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-1.37%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.2B
AUM Growth
+$2.05B
(+17%)
Cap. Flow
+$2.32B
Cap. Flow
% of AUM
16.35%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
921
New
139
Increased
425
Reduced
185
Closed
46
Top Buys
| 1 |
Apple
AAPL
|
$199M |
| 2 |
Microsoft
MSFT
|
$181M |
| 3 |
Tesla
TSLA
|
$79.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$56.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$55.9M |
Top Sells
| 1 |
Sociedad Química y Minera de Chile
SQM
|
$56.4M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$36.9M |
| 3 |
Meta Platforms (Facebook)
META
|
$32.7M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$28.5M |
| 5 |
Booking.com
BKNG
|
$24.5M |
Sector Composition
| 1 | Healthcare | 31.76% |
| 2 | Technology | 24.47% |
| 3 | Financials | 9.64% |
| 4 | Consumer Discretionary | 7.95% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Host Hotels & Resorts
HST
$12B
| $10.9M | 0.08% |
684,918
+622,979
| +1,006% | +$9.89M |
|
|
ISEE
252
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $10.8M | 0.08% |
602,832
-863,739
| -59% | -$15.5M |
|
|
CTXS
253
DELISTED
Citrix Systems Inc
CTXS
| $10.8M | 0.08% |
103,588
+37,593
| +57% | +$3.91M |
|
254
Nurix Therapeutics
NRIX
$758M
| $10.8M | 0.08% |
825,575
-13,800
| -2% | -$180K |
|
255
MongoDB
MDB
$26.4B
| $10.7M | 0.08% |
54,080
+50,163
| +1,281% | +$9.96M |
|
256
Wabtec
WAB
$33B
| $10.6M | 0.08% |
130,774
+14,108
| +12% | +$1.15M |
|
|
GTM
257
ZoomInfo Technologies
GTM
$3.26B
| $10.6M | 0.07% |
+254,166
| New | +$10.6M |
|
258
Replimune Group
REPL
$494M
| $10.5M | 0.07% |
609,572
+117,068
| +24% | +$2.02M |
|
|
ESGR
259
DELISTED
Enstar Group
ESGR
| $10.4M | 0.07% |
+61,354
| New | +$10.4M |
|
|
ATVI
260
DELISTED
Activision Blizzard Inc.
ATVI
| $10.3M | 0.07% |
138,966
+92,088
| +196% | +$6.85M |
|
261
Fate Therapeutics
FATE
$116M
| $10.3M | 0.07% |
460,436
+236,403
| +106% | +$5.3M |
|
|
262
Booking.com
BKNG
$178B
| $10.3M | 0.07% |
6,267
-14,903
| -70% | -$24.5M |
|
263
Aflac
AFL
$57.2B
| $10.2M | 0.07% |
182,185
+36,548
| +25% | +$2.05M |
|
264
Wells Fargo
WFC
$253B
| $10.2M | 0.07% |
253,771
-11,674
| -4% | -$470K |
|
265
Guardant Health
GH
$7.5B
| $10.2M | 0.07% |
189,050
+39,469
| +26% | +$2.12M |
|
266
PTC Therapeutics
PTCT
$4.55B
| $10.2M | 0.07% |
202,652
| – | – |
|
267
DexCom
DXCM
$31.6B
| $10.2M | 0.07% |
126,069
-1,630
| -1% | -$131K |
|
268
Charles River Laboratories
CRL
$8.07B
| $10.1M | 0.07% |
51,454
-2,353
| -4% | -$463K |
|
269
Genworth Financial
GNW
$3.52B
| $10.1M | 0.07% |
+2,882,014
| New | +$10.1M |
|
270
Robert Half
RHI
$3.77B
| $10M | 0.07% |
130,969
+11,278
| +9% | +$863K |
|
271
UDR
UDR
$13B
| $10M | 0.07% |
239,788
+184,681
| +335% | +$7.7M |
|
272
Sutro Biopharma
STRO
$89.9M
| $9.98M | 0.07% |
1,798,838
+1,736,225
| +2,773% | +$9.64M |
|
273
Nutrien
NTR
$27.4B
| $9.93M | 0.07% |
14,840
+918
| +7% | +$614K |
|
274
Cerence
CRNC
$399M
| $9.88M | 0.07% |
627,117
+3,844
| +0.6% | +$60.5K |
|
|
UMPQ
275
DELISTED
Umpqua Holdings Corp
UMPQ
| $9.84M | 0.07% |
575,571
-319,342
| -36% | -$5.46M |
|